{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:41:21Z","timestamp":1773891681665,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004854","name":"St Antonius Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ahj.2025.107296","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:00:38Z","timestamp":1761930038000},"page":"107296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Routine versus selective protamine administration to reduce bleeding after TAVI: Rationale and design of the POPular ACE TAVI trial"],"prefix":"10.1016","volume":"293","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1368-5499","authenticated-orcid":false,"given":"Dani\u00ebl C.","family":"Overduin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk Jan","family":"van Ginkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Lesizza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gijs M.","family":"Broeze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Montero-Cabezas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth","family":"Rosseel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"van der Kley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puck JA","family":"van Nuland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thijs PM","family":"Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberley I.","family":"Hemelrijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo M.","family":"Aarts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benno J.W.M.","family":"Rensing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"Timmers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Swaans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uday","family":"Sonker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"Veenstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnoud W.J.","family":"van 't Hof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"Peper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan G.P.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronak","family":"Delewi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter A.","family":"Vriesendorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurri\u00ebn M.","family":"ten Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2025.107296_bib0001","first-page":"4667","article-title":"ESC\/EACTS Guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"46","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ahj.2025.107296_bib0002","first-page":"e97","article-title":"2020 ACC\/AHA Guideline for the management of patients with valvular Heart disease: executive Summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ahj.2025.107296_bib0003","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.jcin.2023.10.011","article-title":"Bleeding in patients undergoing transfemoral transcatheter aortic valve replacement: incidence, trends, clinical outcomes, and predictors","volume":"16","author":"van Nieuwkerk","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.ahj.2025.107296_bib0004","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s12471-021-01638-8","article-title":"Major threats to early safety after transcatheter aortic valve implantation in a contemporary cohort of real-world patients","volume":"29","author":"van Ginkel","year":"2021","journal-title":"Netherlands Hear J"},{"issue":"7","key":"10.1016\/j.ahj.2025.107296_bib0005","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jacc.2022.11.050","article-title":"Bleeding events after transcatheter aortic valve replacement: JACC State-of-the-art review","volume":"81","author":"Avvedimento","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ahj.2025.107296_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.38578","article-title":"Upper- vs lower-extremity secondary access during transcatheter aortic valve implantation: a randomized clinical trial","volume":"7","author":"Versteeg","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ahj.2025.107296_bib0007","article-title":"Continuation versus interruption of oral anticoagulation during TAVI","author":"van Ginkel","year":"2024","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ahj.2025.107296_bib0008","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jcin.2021.06.020","article-title":"Antithrombotic therapy after transcatheter aortic valve replacement","volume":"14","author":"Capodanno","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2025.107296_bib0009","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2022.05.002","article-title":"Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation","volume":"101","author":"van Ginkel","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"18","key":"10.1016\/j.ahj.2025.107296_bib0010","doi-asserted-by":"crossref","first-page":"e1081","DOI":"10.4244\/EIJ-D-24-01066","article-title":"VARC-HBR criteria validation in TAVI patients on oral anticoagulation","volume":"21","author":"Overduin","year":"2025","journal-title":"EuroIntervention"},{"issue":"23","key":"10.1016\/j.ahj.2025.107296_bib0011","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehab196","volume":"42","author":"ten Berg","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ahj.2025.107296_bib0012","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jcin.2020.03.041","article-title":"Safety and efficacy of Protamine Administration for prevention of bleeding complications in patients undergoing TAVR","volume":"13","author":"Al-Kassou","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.ahj.2025.107296_bib0013","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/clc.23936","article-title":"Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR\u2014A multicenter experience","volume":"46","author":"Al-Kassou","year":"2023","journal-title":"Clin Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2025.107296_bib0014","doi-asserted-by":"crossref","first-page":"995","DOI":"10.33963\/KP.a2021.0070","article-title":"Protamine sulfate during transcatheter aortic valve implantation (PS TAVI) \u2014 A single-center, single-blind, randomized placebo-controlled trial","volume":"79","author":"Zbro\u0144ski","year":"2021","journal-title":"Kardiol Pol"},{"issue":"10","key":"10.1016\/j.ahj.2025.107296_bib0015","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jamacardio.2024.2454","article-title":"Routine protamine administration for bleeding in transcatheter aortic valve implantation: the ACE-PROTAVI randomized clinical trial","volume":"9","author":"Vriesendorp","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"13","key":"10.1016\/j.ahj.2025.107296_bib0016","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2012.01.001","article-title":"2012 ACCF\/AATS\/SCAI\/STS expert consensus document on transcatheter aortic valve replacement","volume":"59","author":"Holmes","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ahj.2025.107296_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2024.2454","article-title":"Routine protamine administration for bleeding in transcatheter aortic valve implantation: the ACE-PROTAVI randomized clinical trial","volume":"9","author":"Vriesendorp","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"19","key":"10.1016\/j.ahj.2025.107296_bib0018","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","article-title":"Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"42","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ahj.2025.107296_bib0019","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"23","key":"10.1016\/j.ahj.2025.107296_bib0020","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ahj.2025.107296_bib0021","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ahj.2025.107296_bib0022","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ahj.2025.107296_bib0023","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12471-013-0496-6","article-title":"Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals","volume":"22","author":"Nijenhuis","year":"2014","journal-title":"Netherlands Hear J"},{"issue":"3\u20134","key":"10.1016\/j.ahj.2025.107296_bib0024","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0049-3848(80)90071-7","article-title":"Effect of protamine on heparin-antithrombin III complexes. In vitro studies","volume":"17","author":"Kitani","year":"1980","journal-title":"Thromb Res"},{"issue":"3\u20134","key":"10.1016\/j.ahj.2025.107296_bib0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0049-3848(80)90072-9","article-title":"Effect of protamine on heparin-antithrombin III complexes. In vivo studies","volume":"17","author":"Kitani","year":"1980","journal-title":"Thromb Res"},{"issue":"1\u20132","key":"10.1016\/j.ahj.2025.107296_bib0026","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0049-3848(81)90028-1","article-title":"Studies on the neutralizing mechanism of antithrombin activity of heparin by protamine","volume":"24","author":"Okajima","year":"1981","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.ahj.2025.107296_bib0027","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00000539-200203000-00008","article-title":"The pharmacokinetics and cardiovascular effects of a single intravenous dose of protamine in normal volunteers","volume":"94","author":"Butterworth","year":"2002","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.ahj.2025.107296_bib0028","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.bja.2018.01.023","article-title":"Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review","volume":"120","author":"Boer","year":"2018","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.ahj.2025.107296_bib0029","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1742-7843.2008.00274.x","article-title":"Serious anaphylactic reactions due to protamine sulfate: a systematic literature review","volume":"103","author":"Nybo","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"12","key":"10.1016\/j.ahj.2025.107296_bib0030","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jcin.2020.03.041","article-title":"Safety and efficacy of Protamine Administration for prevention of bleeding complications in patients undergoing TAVR","volume":"13","author":"Al-Kassou","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.ahj.2025.107296_bib0031","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.jcin.2020.04.056","article-title":"Protamine in patients undergoing transcatheter aortic valve replacement: why not?","volume":"13","author":"ten Berg","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.ahj.2025.107296_bib0032","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/clc.23936","article-title":"Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR\u2014A multicenter experience","volume":"46","author":"Al-Kassou","year":"2022","journal-title":"Clin Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2025.107296_bib0033","first-page":"306","article-title":"Use of protamine sulfate during transfemoral transcatheter aortic valve implantation \u2013 a preliminary assessment of administration rate and impact on complications","volume":"16","author":"Zbro\u0144ski","year":"2020","journal-title":"Adv Interv Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325003588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325003588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:00:12Z","timestamp":1773882012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870325003588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"alternative-id":["S0002870325003588"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2025.107296","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Routine versus selective protamine administration to reduce bleeding after TAVI: Rationale and design of the POPular ACE TAVI trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2025.107296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107296"}}